Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 2/20 | 0.40 |
| ▸ | FNTB | P49356 | 2/20 | 0.40 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.40 |
| ▸ | CASP2 | P42575 | 1/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27112953 | 0.81 | CASP2 (0.61) | CASP2SLC6A5FAAHNAAADNM1 | |
| SCHEMBL13225553 | 0.80 | ALDH1A1 (0.58) | ALDH1A1CASP2FAAHTSHRMEN1 | |
| SCHEMBL7063396 | 0.80 | — | — | |
| SCHEMBL6139361 | 0.80 | CASP2 (0.65) | CASP2SLC6A5FAAHNAAADNM1 | |
| SCHEMBL20542925 | 0.80 | CASP2 (0.65) | CASP2SLC6A5FAAHNAAADNM1 | |
| SCHEMBL24087524 | 0.80 | CASP2 (0.65) | CASP2SLC6A5FAAHNAAADNM1 | |
| SCHEMBL20543068 | 0.80 | CASP2 (0.65) | CASP2SLC6A5FAAHNAAADNM1 | |
| SCHEMBL21842282 | 0.80 | CASP2 (0.65) | CASP2SLC6A5FAAHNAAADNM1 | |
| SCHEMBL6705928 | 0.80 | CASP2 (0.65) | CASP2SLC6A5FAAHNAAADNM1 | |
| SCHEMBL6139231 | 0.80 | CASP2 (0.65) | CASP2SLC6A5FAAHNAAADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7964410-B2 | Method for preparing analysis sample, analysis sample and sugar chain capture agent | SUMITOMO BAKELITE COMPANY, LTD. (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20090068752-A1 | Method for Preparing Analysis Sample, Analysis Sample and Sugar Chain Capture Agent | SUMITOMO BAKELITE COMPANY LIMITED (JP) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068752-A1 | Method for Preparing Analysis Sample, Analysis Sample and Sugar Chain Capture Agent | SI, MGAM, GALE | ALDH1A1 2686/4885FNTA 3727/4885FNTB 4222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.